DuoMab: A Novel CrossMab-based IgG-derived Antibody Format for Enhanced Antibody-Dependent Cell-Mediated Cytotoxicity

mAbs - United States
doi 10.1080/19420862.2019.1661736
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Liver Diseases

Acta Hepatologica Japonica
Hepatology
1980English

Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison With an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay

AAPS Journal
Pharmaceutical Science
2018English

The Roles of Β-Lymphotoxin in Antibody Dependent Cell-Mediated Cytotoxicity

Japanese Journal of Clinical Immunology
1980English

Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1

Cancer Letters
Cancer ResearchOncology
2019English

Bromohydrin Pyrophosphate Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Induced by Therapeutic Antibodies

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity

Oncology Letters
Cancer ResearchOncology
2020English

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1

Frontiers in Immunology
AllergyImmunology
2019English

Enhancement of Antibody-Dependent Cell-Mediated Cytotoxicity of Herpesvirus-Infected Cells by Complement.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1977English

Quantitative Evaluation of Fucose Reducing Effects in a Humanized Antibody on Fcγ Receptor Binding and Antibody-Dependent Cell-Mediated Cytotoxicity Activities

mAbs
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy